Full Text View
Tabular View
No Study Results Posted
Related Studies
A Controlled Study of Olanzapine in Children With Autism
This study is currently recruiting participants.
Study NCT00057408   Information provided by FDA Office of Orphan Products Development
First Received: April 1, 2003   Last Updated: July 1, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Autistic Disorder
Additional conditions recognized in this trial
Disease
More general conditions related to this trial
Child Development Disorders, Pervasive
Mental Disorders
Mental Disorders Diagnosed in Childhood
Pathologic Processes
Interventions listed in this trial
olanzapine (Zyprexa)
Placebo
Additional drug interventions recognized in this trial
Antipsychotic Agents
Olanzapine
More general drug interventions related to this trial
Antiemetics
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
FDA Office of Orphan Products Development
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services